Draeger, Inc. has initiated a manufacturer correction for its Atlan A350 and A350XL anesthesia workstations following FDA notification of a significant manufacturing defect. The identified production error poses a ventilator failure risk that may occur before initial use or during active patient ventilation, creating a serious perioperative safety concern.
The defect classification falls under FDA medical device safety oversight protocols, requiring immediate corrective action across affected healthcare facilities. Operating theatre teams rely on consistent equipment performance during critical patient care moments, making this correction essential for maintaining patient safety standards.
Healthcare institutions currently using these workstation models are advised to contact Draeger directly for guidance on corrective measures and equipment verification protocols. Institutional leadership should ensure clinical staff awareness of potential risks and follow manufacturer recommendations until the issue is fully resolved. Read the full article on GMJ Newsroom.
Was this article helpful?
